Montreal, August 7, 2025 – Bioeureka™, a leader in innovative technologies in the field of applied microbiology, announces the official launch of MicroSelect™, a unique triple-agar Petri dish designed to optimize bacterial detection in clinical, research, and food industry laboratories.
MicroSelect™ combines three carefully compartmentalized selective and differential culture media on a single plate: TSA + 5% blood, MacConkey, and MSA. This innovative configuration allows for the simultaneous seeding of up to three different bacterial strains without risk of cross-contamination, thanks to a perfectly sealed physical separation between the compartments.
This unique approach allows:
- Fast and reliable bacterial screening
- A significant reduction in consumables costs
- A reduction in laboratory handling
- Saves space and time
- Easy reading for technicians and perfect compatibility with artificial intelligence image recognition technologies.
Available at the affordable price of $8.99, MicroSelect™ is proving to be an indispensable tool for professionals who value efficiency and scientific rigor.
“With MicroSelect™, we are simplifying bacterial detection processes while enhancing the reliability and accessibility of diagnostics. This product is the result of our commitment to making microbiology more effective, everywhere in the world.”
– says Mohamed M. Diallo, founder and CEO of Bioeureka.
Seamless integration into the Bioeureka process
MicroSelect™ integrates seamlessly into the intelligent workflow developed by Bioeureka. The process is simple:
- Sample taken from a production line (option to enrich in
broth if necessary) - Seeding on the MicroSelect™ plate
- Incubation 12–24h
- Selecting a colony, spreading on a slide
- AI analysis by Bioeureka (AIMO platform)
- Validation by rapid chemical test
This workflow speeds up diagnosis, reduces human error, and enables accurate identification
of pathogens such as E. coli, Salmonella, S. aureus, P. aeruginosa, etc. at
low cost.
About Bioeureka
Bioeureka is at the forefront of innovation in microbiology, offering portable, AI-powered solutions for rapid pathogen identification. Founded by Mohamed M. Diallo, the company aims to make healthcare and industrial processes safer, more accessible, and more affordable on a global scale. To learn more or request a free sample of MicroSelect™, visit https://bioeureka.com/fr/microselect-2/
Contact presse :
Mohamed M. Diallo
Fondateur & PDG – Bioeureka
mohamed@bioeureka.com
This document is available in French only.
